Patent No. EP4324851 (titled "Chimeric Antigen Receptors With Bcma Specificity And Uses Thereof") was filed by Regeneron Pharmaceuticals on Jul 18, 2019. The application was issued on Aug 27, 2025.

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents